Usana Health Sciences Inc (USNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering USNA.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
USNA reports an average of 23.75% for its upside potential over the past 26 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
USNA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- USNA has a higher average analyst price target than 84.24% of all US stocks.
- Usana Health Sciences Inc's number of analysts covering the stock is higher than 6.44% of stocks in the mid market cap category.
- USNA has a greater upside potential (average analyst target price relative to current price) than 8.27% of Pharmaceutical Products stocks.
- USNA has a lower variance in analysts' estimates than 65.48% of Pharmaceutical Products stocks.
Make investment decisions regarding USNA using the data that counts. Try POWR Ratings for free.